MD1629Z - Фитотерапевтическая пищевая добавка против SARS-CoV-2 - Google Patents
Фитотерапевтическая пищевая добавка против SARS-CoV-2 Download PDFInfo
- Publication number
- MD1629Z MD1629Z MDS20210062A MDS20210062A MD1629Z MD 1629 Z MD1629 Z MD 1629Z MD S20210062 A MDS20210062 A MD S20210062A MD S20210062 A MDS20210062 A MD S20210062A MD 1629 Z MD1629 Z MD 1629Z
- Authority
- MD
- Moldova
- Prior art keywords
- root
- sars
- cov
- aerial part
- phytotherapeutic
- Prior art date
Links
- 239000002778 food additive Substances 0.000 title 1
- 235000013373 food additive Nutrition 0.000 title 1
- 235000015872 dietary supplement Nutrition 0.000 claims abstract description 18
- 235000003261 Artemisia vulgaris Nutrition 0.000 claims abstract description 9
- 240000006891 Artemisia vulgaris Species 0.000 claims abstract description 9
- 241001426527 Rhaponticum Species 0.000 claims abstract description 9
- 240000003291 Armoracia rusticana Species 0.000 claims abstract description 8
- 235000011330 Armoracia rusticana Nutrition 0.000 claims abstract description 8
- 240000007049 Juglans regia Species 0.000 claims abstract description 8
- 235000009496 Juglans regia Nutrition 0.000 claims abstract description 8
- 244000303040 Glycyrrhiza glabra Species 0.000 claims abstract description 7
- 235000006200 Glycyrrhiza glabra Nutrition 0.000 claims abstract description 7
- 239000001841 zingiber officinale Substances 0.000 claims abstract description 7
- 235000009051 Ambrosia paniculata var. peruviana Nutrition 0.000 claims abstract description 6
- 235000003097 Artemisia absinthium Nutrition 0.000 claims abstract description 6
- 235000017731 Artemisia dracunculus ssp. dracunculus Nutrition 0.000 claims abstract description 6
- 239000001138 artemisia absinthium Substances 0.000 claims abstract description 6
- KDYFGRWQOYBRFD-UHFFFAOYSA-N succinic acid Chemical compound OC(=O)CCC(O)=O KDYFGRWQOYBRFD-UHFFFAOYSA-N 0.000 claims abstract description 6
- 235000020234 walnut Nutrition 0.000 claims abstract description 6
- 235000017443 Hedysarum boreale Nutrition 0.000 claims abstract description 5
- 235000007858 Hedysarum occidentale Nutrition 0.000 claims abstract description 5
- 239000000284 extract Substances 0.000 claims abstract description 5
- 229940102465 ginger root Drugs 0.000 claims abstract description 5
- 239000001947 glycyrrhiza glabra rhizome/root Substances 0.000 claims abstract description 5
- 241001533104 Tribulus terrestris Species 0.000 claims abstract description 3
- 241000212322 Levisticum officinale Species 0.000 claims description 7
- 239000001645 levisticum officinale Substances 0.000 claims description 7
- 235000004355 Artemisia lactiflora Nutrition 0.000 claims description 2
- 244000067505 Xanthium strumarium Species 0.000 claims description 2
- 244000273928 Zingiber officinale Species 0.000 claims description 2
- 235000006886 Zingiber officinale Nutrition 0.000 claims description 2
- 235000008397 ginger Nutrition 0.000 claims description 2
- 241001678559 COVID-19 virus Species 0.000 abstract description 17
- 230000003308 immunostimulating effect Effects 0.000 abstract description 10
- 239000003814 drug Substances 0.000 abstract description 4
- 230000005764 inhibitory process Effects 0.000 abstract description 4
- 235000013305 food Nutrition 0.000 abstract description 3
- 241000219196 Armoracia Species 0.000 abstract 1
- 235000003826 Artemisia Nutrition 0.000 abstract 1
- 240000007571 Consolida ajacis Species 0.000 abstract 1
- 241000202807 Glycyrrhiza Species 0.000 abstract 1
- 241000758789 Juglans Species 0.000 abstract 1
- 235000013757 Juglans Nutrition 0.000 abstract 1
- 241000212321 Levisticum Species 0.000 abstract 1
- 235000016639 Syzygium aromaticum Nutrition 0.000 abstract 1
- 244000223014 Syzygium aromaticum Species 0.000 abstract 1
- 241001506766 Xanthium Species 0.000 abstract 1
- 235000009052 artemisia Nutrition 0.000 abstract 1
- LTINPJMVDKPJJI-UHFFFAOYSA-N iodinated glycerol Chemical compound CC(I)C1OCC(CO)O1 LTINPJMVDKPJJI-UHFFFAOYSA-N 0.000 abstract 1
- ZFXYFBGIUFBOJW-UHFFFAOYSA-N theophylline Chemical compound O=C1N(C)C(=O)N(C)C2=C1NC=N2 ZFXYFBGIUFBOJW-UHFFFAOYSA-N 0.000 abstract 1
- 229960000278 theophylline Drugs 0.000 abstract 1
- 239000008280 blood Substances 0.000 description 12
- 210000004369 blood Anatomy 0.000 description 12
- 238000011282 treatment Methods 0.000 description 12
- 239000000203 mixture Substances 0.000 description 10
- 239000013589 supplement Substances 0.000 description 9
- 230000036772 blood pressure Effects 0.000 description 6
- 239000002775 capsule Substances 0.000 description 6
- 230000006502 antiplatelets effects Effects 0.000 description 5
- 238000012360 testing method Methods 0.000 description 4
- 102000008946 Fibrinogen Human genes 0.000 description 3
- 108010049003 Fibrinogen Proteins 0.000 description 3
- 208000036142 Viral infection Diseases 0.000 description 3
- 230000002776 aggregation Effects 0.000 description 3
- 238000004220 aggregation Methods 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- 229940012952 fibrinogen Drugs 0.000 description 3
- 208000015181 infectious disease Diseases 0.000 description 3
- 239000004615 ingredient Substances 0.000 description 3
- 238000002360 preparation method Methods 0.000 description 3
- 230000009385 viral infection Effects 0.000 description 3
- 206010067484 Adverse reaction Diseases 0.000 description 2
- 208000010470 Ageusia Diseases 0.000 description 2
- 206010002653 Anosmia Diseases 0.000 description 2
- 208000025721 COVID-19 Diseases 0.000 description 2
- 206010008479 Chest Pain Diseases 0.000 description 2
- 206010011224 Cough Diseases 0.000 description 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 2
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 2
- 108060003951 Immunoglobulin Proteins 0.000 description 2
- 206010068319 Oropharyngeal pain Diseases 0.000 description 2
- 201000007100 Pharyngitis Diseases 0.000 description 2
- 208000036071 Rhinorrhea Diseases 0.000 description 2
- 206010039101 Rhinorrhoea Diseases 0.000 description 2
- 235000001466 Ribes nigrum Nutrition 0.000 description 2
- 241001312569 Ribes nigrum Species 0.000 description 2
- 208000037847 SARS-CoV-2-infection Diseases 0.000 description 2
- 244000151637 Sambucus canadensis Species 0.000 description 2
- 235000018735 Sambucus canadensis Nutrition 0.000 description 2
- 230000006838 adverse reaction Effects 0.000 description 2
- 230000000840 anti-viral effect Effects 0.000 description 2
- 239000003146 anticoagulant agent Substances 0.000 description 2
- 230000003078 antioxidant effect Effects 0.000 description 2
- 235000007123 blue elder Nutrition 0.000 description 2
- 230000003247 decreasing effect Effects 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 208000017574 dry cough Diseases 0.000 description 2
- 230000004064 dysfunction Effects 0.000 description 2
- 235000007124 elderberry Nutrition 0.000 description 2
- 235000008995 european elder Nutrition 0.000 description 2
- 239000007903 gelatin capsule Substances 0.000 description 2
- 239000008103 glucose Substances 0.000 description 2
- 230000002218 hypoglycaemic effect Effects 0.000 description 2
- 102000018358 immunoglobulin Human genes 0.000 description 2
- 230000002401 inhibitory effect Effects 0.000 description 2
- HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 description 2
- 238000000034 method Methods 0.000 description 2
- 210000003300 oropharynx Anatomy 0.000 description 2
- 229920003023 plastic Polymers 0.000 description 2
- 230000000241 respiratory effect Effects 0.000 description 2
- DBHODFSFBXJZNY-UHFFFAOYSA-N 2,4-dichlorobenzyl alcohol Chemical compound OCC1=CC=C(Cl)C=C1Cl DBHODFSFBXJZNY-UHFFFAOYSA-N 0.000 description 1
- 201000001320 Atherosclerosis Diseases 0.000 description 1
- 241000711573 Coronaviridae Species 0.000 description 1
- 229920002785 Croscarmellose sodium Polymers 0.000 description 1
- 206010061818 Disease progression Diseases 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 241000709661 Enterovirus Species 0.000 description 1
- 201000005569 Gout Diseases 0.000 description 1
- 206010019280 Heart failures Diseases 0.000 description 1
- 206010019663 Hepatic failure Diseases 0.000 description 1
- 241000713772 Human immunodeficiency virus 1 Species 0.000 description 1
- 241000713340 Human immunodeficiency virus 2 Species 0.000 description 1
- 206010020772 Hypertension Diseases 0.000 description 1
- 229920000168 Microcrystalline cellulose Polymers 0.000 description 1
- WHNWPMSKXPGLAX-UHFFFAOYSA-N N-Vinyl-2-pyrrolidone Chemical compound C=CN1CCCC1=O WHNWPMSKXPGLAX-UHFFFAOYSA-N 0.000 description 1
- 235000011483 Ribes Nutrition 0.000 description 1
- 241000220483 Ribes Species 0.000 description 1
- 235000016954 Ribes hudsonianum Nutrition 0.000 description 1
- 241000315672 SARS coronavirus Species 0.000 description 1
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 1
- LEHOTFFKMJEONL-UHFFFAOYSA-N Uric Acid Chemical compound N1C(=O)NC(=O)C2=C1NC(=O)N2 LEHOTFFKMJEONL-UHFFFAOYSA-N 0.000 description 1
- TVWHNULVHGKJHS-UHFFFAOYSA-N Uric acid Natural products N1C(=O)NC(=O)C2NC(=O)NC21 TVWHNULVHGKJHS-UHFFFAOYSA-N 0.000 description 1
- DPXJVFZANSGRMM-UHFFFAOYSA-N acetic acid;2,3,4,5,6-pentahydroxyhexanal;sodium Chemical compound [Na].CC(O)=O.OCC(O)C(O)C(O)C(O)C=O DPXJVFZANSGRMM-UHFFFAOYSA-N 0.000 description 1
- 239000012675 alcoholic extract Substances 0.000 description 1
- CKGWFZQGEQJZIL-UHFFFAOYSA-N amylmetacresol Chemical compound CCCCCC1=CC=C(C)C=C1O CKGWFZQGEQJZIL-UHFFFAOYSA-N 0.000 description 1
- 229960005213 amylmetacresol Drugs 0.000 description 1
- 230000003276 anti-hypertensive effect Effects 0.000 description 1
- 230000002421 anti-septic effect Effects 0.000 description 1
- 229940064004 antiseptic throat preparations Drugs 0.000 description 1
- 239000006286 aqueous extract Substances 0.000 description 1
- 229940075614 colloidal silicon dioxide Drugs 0.000 description 1
- 229960001681 croscarmellose sodium Drugs 0.000 description 1
- 235000010947 crosslinked sodium carboxy methyl cellulose Nutrition 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 229960004698 dichlorobenzyl alcohol Drugs 0.000 description 1
- 230000005750 disease progression Effects 0.000 description 1
- 235000019441 ethanol Nutrition 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- ZCGNOVWYSGBHAU-UHFFFAOYSA-N favipiravir Chemical compound NC(=O)C1=NC(F)=CNC1=O ZCGNOVWYSGBHAU-UHFFFAOYSA-N 0.000 description 1
- 229950008454 favipiravir Drugs 0.000 description 1
- 239000007888 film coating Substances 0.000 description 1
- 238000009501 film coating Methods 0.000 description 1
- 229940072221 immunoglobulins Drugs 0.000 description 1
- 206010022000 influenza Diseases 0.000 description 1
- 230000035987 intoxication Effects 0.000 description 1
- 231100000566 intoxication Toxicity 0.000 description 1
- 201000002364 leukopenia Diseases 0.000 description 1
- 231100001022 leukopenia Toxicity 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 208000007903 liver failure Diseases 0.000 description 1
- 231100000835 liver failure Toxicity 0.000 description 1
- 235000019359 magnesium stearate Nutrition 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 235000012054 meals Nutrition 0.000 description 1
- QSHDDOUJBYECFT-UHFFFAOYSA-N mercury Chemical group [Hg] QSHDDOUJBYECFT-UHFFFAOYSA-N 0.000 description 1
- 229910052753 mercury Inorganic materials 0.000 description 1
- 229940016286 microcrystalline cellulose Drugs 0.000 description 1
- 235000019813 microcrystalline cellulose Nutrition 0.000 description 1
- 239000008108 microcrystalline cellulose Substances 0.000 description 1
- HYIMSNHJOBLJNT-UHFFFAOYSA-N nifedipine Chemical compound COC(=O)C1=C(C)NC(C)=C(C(=O)OC)C1C1=CC=CC=C1[N+]([O-])=O HYIMSNHJOBLJNT-UHFFFAOYSA-N 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- 230000001717 pathogenic effect Effects 0.000 description 1
- 230000001575 pathological effect Effects 0.000 description 1
- 230000007170 pathology Effects 0.000 description 1
- 239000008194 pharmaceutical composition Substances 0.000 description 1
- 239000000419 plant extract Substances 0.000 description 1
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 description 1
- 229920000036 polyvinylpyrrolidone Polymers 0.000 description 1
- 229940069328 povidone Drugs 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 238000011321 prophylaxis Methods 0.000 description 1
- 239000008213 purified water Substances 0.000 description 1
- 210000000614 rib Anatomy 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- UFTFJSFQGQCHQW-UHFFFAOYSA-N triformin Chemical compound O=COCC(OC=O)COC=O UFTFJSFQGQCHQW-UHFFFAOYSA-N 0.000 description 1
- 241000701161 unidentified adenovirus Species 0.000 description 1
- 241001430294 unidentified retrovirus Species 0.000 description 1
- 229940116269 uric acid Drugs 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
Изобретение относится к пищевой промышленности, санокреатологии и медицине, в частности к биологически активной фитотерапевтической пищевой добавке, обладающей иммуностимулирующей активностью с ингибированием вируса SARS-CoV-2.Пищевая добавка, согласно изобретению, содержит сухие экстракты из, в %масс.: надземной части полыни обыкновенной, Artemisia vulgaris16±3надземной части дурнишника, Xanthium strumarium16±3надземной части корня марала, Rhaponticum carthamoides6 ±2кожуры грецкого ореха, Juglans regia11±2корня хрена, Armoracia rusticana10±3надземной части любистка, Levisticum officinale13±3трибулуса, Tribulus terrestris L16±3корня имбиря, Zingiber officinale6±2корня солодки, Glycyrrhiza glabra6±2.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| MDS20210062A MD1629Z (ru) | 2021-07-22 | 2021-07-22 | Фитотерапевтическая пищевая добавка против SARS-CoV-2 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| MDS20210062A MD1629Z (ru) | 2021-07-22 | 2021-07-22 | Фитотерапевтическая пищевая добавка против SARS-CoV-2 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| MD1629Y MD1629Y (ru) | 2022-06-30 |
| MD1629Z true MD1629Z (ru) | 2023-01-31 |
Family
ID=82214071
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MDS20210062A MD1629Z (ru) | 2021-07-22 | 2021-07-22 | Фитотерапевтическая пищевая добавка против SARS-CoV-2 |
Country Status (1)
| Country | Link |
|---|---|
| MD (1) | MD1629Z (ru) |
-
2021
- 2021-07-22 MD MDS20210062A patent/MD1629Z/ru not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| MD1629Y (ru) | 2022-06-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Roxas et al. | Colds and influenza: a review of diagnosis and conventional, botanical, and nutritional considerations. | |
| US6576267B2 (en) | Composition and method for treating the effects of diseases and maladies | |
| US6787164B2 (en) | Composition and method for treating the effects of diseases and maladies | |
| US20020004078A1 (en) | Composition and method for treating the effects of diseases and maladies | |
| JP5578646B2 (ja) | 咽頭炎用及びインフルエンザ予防・治療用の経口投与組成物 | |
| CN109476701A (zh) | 包含环组氨酸-脯氨酸作为有效成分的用于保护细胞的组合物 | |
| Majeed et al. | A randomized, double‐blind, placebo‐controlled study to assess the efficacy and safety of a nutritional supplement (ImmuActiveTM) for COVID‐19 patients | |
| CA2839972C (en) | Compositions containing broccoli seeds extract for treating or preventing prostate cancer | |
| Rethinam et al. | Health benefits of coconut water | |
| MD1629Z (ru) | Фитотерапевтическая пищевая добавка против SARS-CoV-2 | |
| US6440451B1 (en) | Use of crataegus formulations for prophylaxis and treatment of neoplastic diseases | |
| WO2021179616A1 (zh) | 小柴胡颗粒联合磷酸氯喹的新应用 | |
| MD1532Z (ru) | Пищевая фитотерапевтическая добавка антиSARS-CoV-2 | |
| MD1533Z (ru) | Пищевая фитотерапевтическая добавка антиSARS-CoV-2 | |
| MD1531Z (ru) | Пищевая фитотерапевтическая добавка антиSARS-CoV-2 | |
| Kumar et al. | Allium sativum and its health benefits: An overview | |
| KR20140030360A (ko) | 홍삼을 유효성분으로 함유하는 인플루엔자 의사 증상의 예방 및 개선을 위한 조성물 | |
| MD1541Z (ru) | Метод лечения инфекции вирусом SARS-CoV-2 средней формы | |
| CN113476438B (zh) | 含二氢桑色素的降血糖组合物及其应用 | |
| CN113521057B (zh) | 含染料木素的降血糖组合物及其应用 | |
| CN102068537B (zh) | 陈皮甘草制备防治鼻咽癌的保健食品和药品的生产方法 | |
| Ibraheem | A Comparative Study of the Antiulcerogenic Effect of Hydroethanol and Fractionated Extracts of Verbena hastata Leaves on Indomethacine Induced Gastric Ulcer in Albino Rats | |
| CN116392476A (zh) | 协同抑制胰脂肪酶的组合物及其应用 | |
| US9629887B1 (en) | Control of acid reflux with botanicals | |
| UA148159U (uk) | Спосіб виготовлення препарату (дієтичної добавки) "тіреоклін" |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FG9Y | Short term patent issued | ||
| KA4Y | Short-term patent lapsed due to non-payment of fees (with right of restoration) | ||
| MM4Y | Short-term patent definitely lapsed due to non-payment of fees |